Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs BP✓SelectedUSD · BPMRNA vs BP performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs BP

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+147.0%
BP return
+39.9%
Excess return
+107.1%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioBPExcessAlpha
1D-2.2%-1.1%-1.1%-2.0%
7D-12.7%-6.5%-6.2%-12.0%
30D-20.7%-13.3%-7.4%-19.4%
3M+46.3%-4.2%+50.5%+45.8%
6M+305.2%-3.0%+308.2%+303.8%
YTD+561.2%+29.1%+532.1%+482.0%
1Y+772.1%+25.6%+746.5%+673.2%
3Y+147.0%+39.9%+107.1%+101.2%
All+147.0%+39.9%+107.1%+101.2%

Cumulative growth

Daily Returns

Daily percentage return beside BP.

Daily Out/Under-Performance

Portfolio return minus BP return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × BP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded BP wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling